MML Investors Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MML Investors Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,968	Closed	-$870K	–	2366
2023 Q1	$870K	Sell	7,968 -6,693	-46%	-$740K	0.01%	1135
2022 Q4	$1.67M	Buy	14,661 +1,478	+11%	+$123K	0.01%	904
2022 Q3	$816K	Buy	13,183 +1,326	+11%	+$92.7K	0.01%	1161
2022 Q2	$946K	Buy	11,857 +1,471	+14%	+$139K	0.01%	1067
2022 Q1	$1.09M	Buy	10,386 +1,833	+21%	+$179K	0.01%	1039
2021 Q4	$922K	Buy	8,553 +370	+5%	+$40.4K	0.01%	1096
2021 Q3	$896K	Buy	8,183 +217	+3%	+$22.5K	0.01%	1063
2021 Q2	$746K	Sell	7,966 -530	-6%	-$48.8K	0.01%	1136
2021 Q1	$782K	Buy	8,496 +2,395	+39%	+$202K	0.01%	1042
2020 Q4	$446K	Sell	6,101 -240	-4%	-$17.8K	﹤0.01%	1212
2020 Q3	$493K	Buy	+6,341	New	+$436K	0.01%	1050

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MML Investors Services's HZNP Position: Q2 2023 in Review

MML Investors Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 7,968 shares — an estimated $870K sold.

MML Investors Services first reported a position in HZNP in Q3 2020 and held it in 11 quarters. The position peaked at $1.67M in Q4 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

MML Investors Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
MML Investors Services sold 7,968 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $870K.
MML Investors Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 11 quarters.
MML Investors Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.67M in Q4 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on MML Investors Services's 13F filing for Q2 2023, filed 14 Aug 2023.